SCHEMBL22953344

SCHEMBL22953344

COc1cc(OC)c2c3c1CNCC3c1ccc(O)c(O)c1O2

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.39
DRD1 P21728 4/20 0.39
DRD5 P21918 4/20 0.39
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
CYP3A4 P08684 2/20 0.32
CETP P11597 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
THPO P40225 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX5 P09917 1/20 0.32
PTPN1 P18031 1/20 0.32
PPARG P37231 1/20 0.32
PPARD Q03181 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22953343 0.80 PARP1 (0.41) PARP1DRD1CYP3A4ALOX15TSHR
SCHEMBL22952987 0.80 PARP1 (0.41) PARP1DRD1DRD5CHRNB2CHRNA4
SCHEMBL22952973 0.76 PARP1 (0.38) PARP1CYP3A4ALOX15TSHRNFKB1
SCHEMBL22953341 0.75 PARP1 (0.43) PARP1DRD1DRD5CYP3A4ALOX15
SCHEMBL22952977 0.73 DRD1 (0.33) PARP1DRD1DRD5CYP3A4ALOX15
SCHEMBL22952976 0.69 HTR2A (0.33) PARP1DRD1CYP3A4ALOX15TSHR
SCHEMBL6345215 0.69 HTR2A (0.46) PARP1DRD1DRD5CYP3A4ALOX15
SCHEMBL29383649 0.69 HTR2A (0.46) PARP1DRD1DRD5CYP3A4ALOX15
Bromide SCHEMBL3668719 0.68 HTR2A (0.45) PARP1DRD1CYP3A4ALOX15TSHR
SCHEMBL22952971 0.66 HTR2A (0.35) PARP1DRD1CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed